Trials / Completed
CompletedNCT01688531
A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
Exploratory, international, multi-centre, randomized, investigator blinded study in acne
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CD0271 0.1%/CD1579 2.5% gel | one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months |
| DRUG | CD0271 0.1%/CD1579 2.5% gel vehicle | one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2012-09-20
- Last updated
- 2019-09-18
Locations
3 sites across 2 countries: Canada, France
Source: ClinicalTrials.gov record NCT01688531. Inclusion in this directory is not an endorsement.